Active
Bill · 119th Congress · S 4189
INSULIN Act of 2026
Refreshed 33 min ago
Introduced 2026-03-25Topic: health care · public healthSummary
AI-generated summary, report an errorStarting with plan years that begin on or after January 1, 2028, this bill would require group health plans and insurers selling group or individual coverage to cover at least one insulin product of each type and dosage form. For those selected insulin products, plans could not apply a deductible. They also could not charge more per 30-day supply than the lesser of $35 or 25 percent of the plan's net negotiated price. Plans could not require prior authorization for these products except for safety reasons, reasonable quantity limits, or as the Secretary specifies, and catastrophic plans would have to cover them before the deductible is met. The bill also directs the Government Accountability Office to study uninsured people who use insulin and includes changes to how citizen petitions affecting generic drug approvals are handled.
Sponsors
- Jeanne Shaheen Democrat sponsor
- 28 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-08-07 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 552. | |
| 2026-08-07 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report. | refer |
| 2026-08-07 | Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report. | report | |
| 2026-07-22 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. | refer |
| 2026-03-25 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | refer |
| 2026-03-25 | Introduced in Senate | introduce |